AU2004311869A1 - Compositions and methods to treat recurrent medical conditions - Google Patents
Compositions and methods to treat recurrent medical conditions Download PDFInfo
- Publication number
- AU2004311869A1 AU2004311869A1 AU2004311869A AU2004311869A AU2004311869A1 AU 2004311869 A1 AU2004311869 A1 AU 2004311869A1 AU 2004311869 A AU2004311869 A AU 2004311869A AU 2004311869 A AU2004311869 A AU 2004311869A AU 2004311869 A1 AU2004311869 A1 AU 2004311869A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- pharmacologic agent
- dcs
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53300303P | 2003-12-29 | 2003-12-29 | |
| US60/533,003 | 2003-12-29 | ||
| US62525304P | 2004-11-05 | 2004-11-05 | |
| US60/625,253 | 2004-11-05 | ||
| PCT/US2004/043628 WO2005065308A2 (en) | 2003-12-29 | 2004-12-29 | Compositions and methods to treat recurrent medical conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2004311869A1 true AU2004311869A1 (en) | 2005-07-21 |
Family
ID=34752985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2004311869A Abandoned AU2004311869A1 (en) | 2003-12-29 | 2004-12-29 | Compositions and methods to treat recurrent medical conditions |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7846913B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1703907A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007517049A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20070007276A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004311869A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2592631A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2006127475A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005065308A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE519485T1 (de) * | 2001-03-29 | 2011-08-15 | Michael Davis | Akute pharmakologische verstärkung einer psychotherapie mit d-cycloserine |
| CA2609972C (en) * | 2004-03-22 | 2013-05-14 | Apkarian Technologies Llc | Method and compositions for treatment of chronic neuropathic pain |
| US20060084659A1 (en) * | 2004-10-19 | 2006-04-20 | Michael Davis | Augmentation of psychotherapy with cannabinoid reuptake inhibitors |
| EP2353590A1 (en) * | 2005-02-15 | 2011-08-10 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| WO2007018801A1 (en) * | 2005-07-28 | 2007-02-15 | Teikoku Pharma Usa, Inc. | Gelled donepezil compositions and methods for making and using the same |
| CA2616366A1 (en) | 2005-07-29 | 2007-02-08 | Concert Pharmaceuticals Inc. | Novel pharmaceutical compounds |
| US20080009502A1 (en) * | 2006-07-07 | 2008-01-10 | Access Business Group International Llc | Tadalafil solid composites |
| US20100113453A1 (en) * | 2007-04-10 | 2010-05-06 | Mcdevitt Jason P | Sublingual Formulations of D-Cycloserine and Methods of Using Same |
| ATE515259T1 (de) * | 2007-05-29 | 2011-07-15 | Lek Pharmaceuticals | Pharmazeutische zusammensetzung mit eszopiclon |
| DE102007028869A1 (de) | 2007-06-22 | 2008-12-24 | Ratiopharm Gmbh | Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil |
| US20100291225A1 (en) * | 2008-01-14 | 2010-11-18 | Jubilant Organosys Ltd. | Stabilized Sustained Release Composition of Bupropion Hydrochloride and Process For Preparing the Same |
| US20100204291A1 (en) * | 2009-02-12 | 2010-08-12 | Mcdevitt Jason P | Method for Facilitating Extinction Training Using D-Cycloserine |
| US9789093B2 (en) | 2011-01-31 | 2017-10-17 | Serotech, Llc | Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| US10583138B2 (en) | 2012-07-12 | 2020-03-10 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| MX336979B (es) * | 2011-12-16 | 2016-02-09 | Senosiain S A De C V Lab | Combinacion farmaceutica antineuritica y composiciones. |
| US9877951B2 (en) | 2015-02-12 | 2018-01-30 | College Of William And Mary | Method for treating dementia |
| US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
| US10485790B1 (en) * | 2018-09-13 | 2019-11-26 | Syneurx International (Taiwan) Corp. | Salts of cycloserine compounds and applications thereof |
| US11291654B2 (en) * | 2018-09-13 | 2022-04-05 | Syneurx International (Taiwan) Corp. | Formulations of cycloserine compounds and applications thereof |
| WO2025173704A1 (ja) * | 2024-02-16 | 2025-08-21 | エフバイタル株式会社 | 薬剤のスクリーニング方法、および剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5061721A (en) | 1989-03-15 | 1991-10-29 | G. D. Searle & Co. | Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder |
| JPH03236315A (ja) * | 1989-12-05 | 1991-10-22 | Nippon Oil & Fats Co Ltd | 抗精神病薬 |
| US5260324A (en) | 1990-02-06 | 1993-11-09 | G. D. Searle & Company | Composition containing D-cycloserine and D-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder |
| US5086072A (en) | 1990-06-18 | 1992-02-04 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex |
| US5428069A (en) | 1993-01-11 | 1995-06-27 | The United States Of America As Represented By The Department Of Health & Human Services | Treating cognition with, aminocyclopropanecarboxylic derivatives |
| US5523323A (en) | 1993-09-14 | 1996-06-04 | Maccecchini; Maria-Luisa | Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence |
| US6355681B2 (en) | 1995-12-07 | 2002-03-12 | Glytech, Inc. | Glycine substitutes and precursors for treating a psychosis |
| US6133281A (en) * | 1996-10-24 | 2000-10-17 | Harbor-Ucla Research And Education Institute | NMDA receptor blockers in the therapy of urogenital disease |
| WO1999051252A1 (en) * | 1998-04-03 | 1999-10-14 | The Daily Wellness Company | Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation |
| AU765603C (en) | 1998-04-14 | 2004-08-05 | General Hospital Corporation, The | Methods for treating neuropsychiatric disorders |
| US6337328B1 (en) * | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
| CA2372073A1 (en) * | 1999-04-29 | 2000-11-09 | Merck Patent Gesellschaft Mit Beschraenkter Haftung | Glycine cleavage system inhibitors as potential antipsychotics |
| US20010053780A1 (en) * | 1999-04-30 | 2001-12-20 | Whitaker John S. | Daily treatment for erectile dysfunction using a PDE5 inhibitor |
| US6333357B1 (en) | 1999-11-05 | 2001-12-25 | Be Able, Llc | Behavior chemotherapy |
| US20050096396A1 (en) | 2002-03-28 | 2005-05-05 | Emory University | Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| ATE519485T1 (de) * | 2001-03-29 | 2011-08-15 | Michael Davis | Akute pharmakologische verstärkung einer psychotherapie mit d-cycloserine |
| GB0129274D0 (en) * | 2001-12-06 | 2002-01-23 | Pfizer Ltd | Novel kit |
| CA2473536A1 (en) * | 2002-01-16 | 2003-07-31 | Endo Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating disorders of the central nervous system |
| GB0322140D0 (en) * | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
-
2004
- 2004-12-29 KR KR1020067015406A patent/KR20070007276A/ko not_active Withdrawn
- 2004-12-29 AU AU2004311869A patent/AU2004311869A1/en not_active Abandoned
- 2004-12-29 JP JP2006547469A patent/JP2007517049A/ja active Pending
- 2004-12-29 RU RU2006127475/14A patent/RU2006127475A/ru not_active Application Discontinuation
- 2004-12-29 EP EP04815650A patent/EP1703907A4/en not_active Withdrawn
- 2004-12-29 US US11/024,921 patent/US7846913B2/en not_active Expired - Fee Related
- 2004-12-29 CA CA002592631A patent/CA2592631A1/en not_active Abandoned
- 2004-12-29 WO PCT/US2004/043628 patent/WO2005065308A2/en not_active Ceased
-
2010
- 2010-11-30 US US12/956,769 patent/US8309535B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20050143314A1 (en) | 2005-06-30 |
| JP2007517049A (ja) | 2007-06-28 |
| US8309535B2 (en) | 2012-11-13 |
| KR20070007276A (ko) | 2007-01-15 |
| RU2006127475A (ru) | 2008-02-10 |
| US20110071102A1 (en) | 2011-03-24 |
| CA2592631A1 (en) | 2005-07-21 |
| EP1703907A2 (en) | 2006-09-27 |
| US7846913B2 (en) | 2010-12-07 |
| WO2005065308A2 (en) | 2005-07-21 |
| EP1703907A4 (en) | 2009-03-25 |
| WO2005065308A3 (en) | 2005-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8309535B2 (en) | Compositions and methods to treat recurrent medical conditions | |
| US20240148756A1 (en) | Use of neuroactive steroid for treatment of sexual dysfunction | |
| US20040029941A1 (en) | Zonisamide use in obesity and eating disorders | |
| US20060252761A1 (en) | Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine | |
| JP2021080276A (ja) | デクスメデトミジン製剤を使用する睡眠障害の予防または治療 | |
| US8703823B2 (en) | Methods for treatment of migraine and symptoms thereof | |
| KR20230136599A (ko) | 성 기능장애의 치료를 위한 신경활성 스테로이드의용도 | |
| CZ2002784A3 (cs) | Způsoby použití selektivních inhibitorů vychytávání serotoninu s rychlým nástupem pro léčení sexuální dysfunkce | |
| US10869857B2 (en) | Melatonin mini-tablets and method of manufacturing the same | |
| NZ506020A (en) | Use of pharmaceutical combinations containing tramadol and an antiemetic | |
| RU2268725C2 (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств | |
| CA2403994C (en) | Nasal administration of agents for the treatment of gastroparesis | |
| CN117177741A (zh) | 用于治疗睡眠呼吸暂停的去甲肾上腺素再摄取抑制剂和大麻素的组合 | |
| US20110244057A1 (en) | Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions | |
| US20150258097A1 (en) | Compositions and methods for the treatment of catatonia | |
| US20140148465A1 (en) | Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine | |
| US20070219201A1 (en) | Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders | |
| KR100692235B1 (ko) | 안지오텐신 ⅱ 길항물질의 신규한 용도 | |
| CN1972685A (zh) | 治疗复发性的需要治疗的病症的组合物及方法 | |
| US20240293435A1 (en) | Methods and Compositions for Treating Human Disorders Using D-Cycloserine and a Psychedelic Agent | |
| HK1100840A (en) | Compositions and methods to treat recurrent medical conditions | |
| IL230174A (en) | Pharmaceutical composition for the treatment of premature ejaculation | |
| WO2002056869A2 (en) | Method for treating sexual disorders | |
| US8680145B1 (en) | Compositions and methods for treatment of fear of medical procedures | |
| US20160263018A1 (en) | Method For Treating Nicotine Withdrawal Symptoms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |